Skip to main content

Client News

Medigene AG: Medigene presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers

24th April 2023

Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture

24th April 2023

Element Materials: bioMérieux and JMI Laboratories partner to fight antimicrobial resistance (AMR)

20th April 2023

Abivax reports 2022 financial results and operations update

19th April 2023

Newron announces AGM 2023 results

18th April 2023

Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics

18th April 2023

InflaRx announces closing of the full exercise of greenshoe option increasing the proceeds of the recently announced public offering of ordinary shares to US$46 million

18th April 2023

Abivax appoints Michael Ferguson as Chief Commercial Officer

18th April 2023

Medigene AG: New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors

18th April 2023

invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023

18th April 2023